Gudrun Pappaert

Gudrun Pappaert

Auto-generated profile, based on publicly available information

Gudrun Pappaert

Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart, Vrije Universiteit Brussel, Universitair Ziekenhuis , Laarbeeklaan 101, Brussel 1090

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2017 in European Heart Journal
Verified
Journal Article
Open access
PDF file
JSJuan Sieira
Juan Sieira
GCGiulio Conte
Giulio Conte
GCGiuseppe Ciconte
Giuseppe Ciconte
GCGian-Battista Chierchia
Gian-Battista Chierchia
RARuben Casado Arroyo
Ruben Casado Arroyo
PBPedro Brugada
Pedro Brugada
Aims: Risk stratification in Brugada Syndrome (BS) remains challenging. Arrhythmic events can occur life-long and studies with long follow-ups are sparse. The aim of our study was to investigate long-term prognosis and risk stratification of BS patients. Methods and results: A single centre consecutive cohort of 400 BS patients was included and analysed. Mean age was 41.1 years, 78 patients (19.5%) had a spontaneous type I electrocardiogram (ECG). Clinical presentation was aborted sudden cardiac death (SCD) in 20 patients (5.0%), syncope in 111 (27.8%) and asymptomatic in 269 (67.3%). Familial antecedents of SCD were found in 184 individuals (46.0%), in 31 (7.8%) occurred in first-degree relatives younger than 35 years. An implantable cardioverter defibrillator (ICD) was placed in 176 (44.0%). During a mean follow-up of 80.7 months, 34 arrhythmic events occurred (event rate: 1.4% year). Variables significantly associated to events were: presentation as aborted SCD (Hazard risk [HR] 20.0), syncope (HR 3.7), spontaneous type I (HR 2.7), male gender (HR 2.7), early SCD in first-degree relatives (HR 2.9), SND (HR 5.0), inducible VA (HR 4.7) and proband status (HR 2.1). A score including ECG pattern, early familial SCD antecedents, inducible electrophysiological study, presentation as syncope or as aborted SCD and SND had a predictive performance of 0.82. A score greater than 2 conferred a 5-year event probability of 9.2%. Conclusions: BS patients remain at risk many years after diagnosis. Early SCD in first-degree relatives and SND are risk factors for arrhythmic events. A simple risk score might help in the stratification and management of BS patients.

1 March 2015 in JACC
Verified
Journal Article
Closed access
GCGiulio Conte
Giulio Conte
JSJuan Sieira
Juan Sieira
GCGiuseppe Ciconte
Giuseppe Ciconte
Carlo de AsmundisCarlo de Asmundis
Carlo de Asmundis
GCGian-Battista Chierchia
Gian-Battista Chierchia
PBPedro Brugada
Pedro Brugada

1 August 2015 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
JSJuan Sieira
Juan Sieira
GCGiulio Conte
Giulio Conte
GCGiuseppe Ciconte
Giuseppe Ciconte
Carlo de AsmundisCarlo de Asmundis
Carlo de Asmundis
GCGian-Battista Chierchia
Gian-Battista Chierchia
PBPedro Brugada
Pedro Brugada
Background—: The prognostic value of electrophysiological investigations in individuals with Brugada syndrome remains controversial. Different groups have published contradictory data. Long-term follow-up is needed to clarify this issue. Methods and Results—: Patients presenting with spontaneous or drug-induced Brugada type I ECG and in whom programmed electric stimulation was performed at our institution were considered eligible for this study. A total of 403 consecutive patients (235 males, 58.2%; mean age, 43.2±16.2 years) were included. Ventricular arrhythmias during programmed electric stimulation were induced in 73 (18.1%) patients. After a mean follow-up time of 74.3±57.3 months (median 57.3), 25 arrhythmic events occurred (16 in the inducible group and 9 in the noninducible). Ventricular arrhythmias inducibility presented a hazard ratio for events of 8.3 (95% confidence interval, 3.6–19.4), P <0.01. Conclusions—: Programmed ventricular stimulation of the heart is a good predictor of outcome in individuals with Brugada syndrome. It might be of special value to guide further management when performed in asymptomatic individuals. The overall accuracy of the test makes it a suitable screening tool to reassure noninducible asymptomatic individuals

1 August 2016 in JACC
Verified
Journal Article
Closed access
RARuben Casado Arroyo
Ruben Casado Arroyo
PBPaola Berne
Paola Berne
JRJayakeerthi Yoganarasimha Rao
Jayakeerthi Yoganarasimha Rao
MRMoisés Rodríguez-Mañero
Moisés Rodríguez-Mañero
MLMoisés Levinstein
Moisés Levinstein
PBPedro Brugada
Pedro Brugada

1 October 2015 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
JSJuan Sieira
Juan Sieira
GCGiuseppe Ciconte
Giuseppe Ciconte
GCGiulio Conte
Giulio Conte
GCGian-Battista Chierchia
Gian-Battista Chierchia
Carlo de AsmundisCarlo de Asmundis
Carlo de Asmundis
PBPedro Brugada
Pedro Brugada
Background—: Among Brugada syndrome patients, asymptomatic individuals are considered to be at the lowest risk. Nevertheless, arrhythmic events and sudden cardiac death are not negligible. Literature focused on this specific group of patients is sparse. The purpose of this study is to investigate the clinical characteristics, management, and long-term prognosis of asymptomatic Brugada syndrome patients. Methods and Results—: Patients presenting with spontaneous or drug-induced Brugada type I ECG and no symptoms at our institution were considered eligible. A total of 363 consecutive patients (200 men, 55.1%; mean age, 40.9±17.2 years; 41 [11.3%] with spontaneous type I ECG) were included. Electrophysiological study was performed in 321 (88.4%) patients, and ventricular arrhythmias were induced in 32 (10%) patients. An implantable cardioverter defibrillator was implanted in 61 (16.8%) patients. After a mean follow-up time of 73.2±58.9 months, 9 arrhythmic events occurred, accounting for an annual incidence rate of 0.5%. Event-free survival was 99.0% at 1 year, 96.2% at 5 years, and 95.4% at 10 and 15 years. Univariate analysis identified as risk factors: electrophysiological study inducibility (hazard ratio, 11.4; P <0.01), spontaneous type I (hazard ratio, 4.0; P =0.04), and previous sinus node dysfunction (hazard ratio, 8.0; 95% confidence interval, 1.0–63.9; P =0.05). At the multivariate analysis, only inducibility remained significant (hazard ratio, 9.1; P <0.01) Conclusions—: Arrhythmic events in asymptomatic Brugada syndrome patients are not insignificant. Ventricular arrhythmia inducibility, spontaneous type I ECG, and presence of sinus node dysfunction might be considered as risk factors and used to drive long-term management.

1 December 2013 in Heart Rhythm
Verified
Journal Article
Closed access
GCGiulio Conte
Giulio Conte
JSJuan Sieira
Juan Sieira
ASAndrea Sarkozy
Andrea Sarkozy
Carlo de AsmundisCarlo de Asmundis
Carlo de Asmundis
GGGiacomo Di Giovanni
Giacomo Di Giovanni
PBPedro Brugada
Pedro Brugada